ODTX ▼ -2.0% - Odyssey Therapeutics, Inc.
$ODTX Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
20-OCT-2026 07:06 AM ET
Share this post
More filings for $ODTX
ODTX ▼ -2.0% - Odyssey Therapeutics, Inc.Oct 20, 2026ODTX ▼ -0.3% - Odyssey Therapeutics, Inc.Oct 12, 2026ODTX ▼ -0.6% - Odyssey Therapeutics, Inc.Oct 6, 2026ODTX ▼ -2.7% - Odyssey Therapeutics, Inc.Sep 16, 2026
View full $ODTX filing history →💬 Comments
Loading comments…
Leave a comment